MARUCCI, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.368
EU - Europa 9.014
AS - Asia 6.644
SA - Sud America 821
AF - Africa 255
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 16
Totale 35.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.815
CN - Cina 2.689
SG - Singapore 1.942
RU - Federazione Russa 1.850
PL - Polonia 1.548
IT - Italia 1.444
DE - Germania 1.131
BR - Brasile 672
GB - Regno Unito 627
FR - Francia 565
HK - Hong Kong 535
UA - Ucraina 508
SE - Svezia 503
VN - Vietnam 499
CA - Canada 459
FI - Finlandia 351
TR - Turchia 242
KR - Corea 212
ZA - Sudafrica 171
IE - Irlanda 127
IN - India 122
JP - Giappone 100
BE - Belgio 80
EU - Europa 71
MX - Messico 69
AR - Argentina 65
NL - Olanda 63
BD - Bangladesh 42
CZ - Repubblica Ceca 41
IR - Iran 38
ES - Italia 36
PK - Pakistan 30
IQ - Iraq 29
EC - Ecuador 25
RO - Romania 23
AT - Austria 22
AE - Emirati Arabi Uniti 18
TW - Taiwan 18
ID - Indonesia 16
CH - Svizzera 15
KE - Kenya 15
CO - Colombia 14
EG - Egitto 14
MA - Marocco 14
LT - Lituania 13
RS - Serbia 13
JO - Giordania 12
PE - Perù 12
SA - Arabia Saudita 12
AU - Australia 11
IL - Israele 11
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
VE - Venezuela 11
AZ - Azerbaigian 10
PH - Filippine 8
LB - Libano 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
CL - Cile 6
HR - Croazia 6
OM - Oman 6
AL - Albania 5
AM - Armenia 5
BY - Bielorussia 5
DZ - Algeria 5
GR - Grecia 5
MY - Malesia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
NO - Norvegia 4
NP - Nepal 4
TH - Thailandia 4
CR - Costa Rica 3
ET - Etiopia 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
LY - Libia 2
MU - Mauritius 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AS - Samoa Americane 1
Totale 35.167
Salva come PNG Salva come JPEG
Città #
Fairfield 1.492
Woodbridge 1.482
Ashburn 1.402
Dallas 1.324
Jacksonville 1.208
Warsaw 1.198
Singapore 995
Chandler 948
San Jose 829
Houston 816
Ann Arbor 709
Wilmington 688
Seattle 637
Cambridge 543
Boardman 511
Hong Kong 504
Beijing 439
Nanjing 409
Kraków 331
Toronto 294
Los Angeles 268
The Dalles 265
Council Bluffs 250
Camerino 239
Istanbul 191
Columbus 187
San Mateo 185
Seoul 183
Düsseldorf 178
New York 177
Helsinki 172
Tongling 167
Lawrence 163
Princeton 163
Ho Chi Minh City 161
Dearborn 158
Johannesburg 154
Lauterbourg 144
Ogden 136
Moscow 133
London 126
Dublin 125
Nanchang 125
Buffalo 119
Lachine 117
Shanghai 111
Munich 105
Milan 104
Santa Clara 104
Hanoi 100
Guangzhou 99
Chicago 90
Kunming 86
Tokyo 82
Brussels 75
San Diego 75
São Paulo 75
Shenyang 67
Tianjin 64
Frankfurt am Main 63
Jiaxing 62
Hebei 61
Orem 59
St Louis 54
Hangzhou 45
Edinburgh 44
Wuhan 39
Denver 38
Philadelphia 38
Rome 38
Centro 37
Venezia 36
Changsha 35
Chennai 35
Ningbo 35
Dong Ket 31
Hefei 31
Redwood City 30
Phoenix 29
Poplar 29
Stockholm 29
Turku 29
Brno 28
Brooklyn 28
San Francisco 28
Jinan 27
Manchester 27
Mexico City 27
Boston 26
Da Nang 26
Trieste 26
Venice 26
Orange 25
Perugia 25
Norwalk 24
Amsterdam 23
Atlanta 23
Falls Church 23
Bremen 22
Hillsboro 22
Totale 23.665
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 611
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 593
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 557
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 531
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 527
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 450
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 403
Overview on Radiolabel-Free in Vitro Assays for GPCRs 399
Pharmacological characterization of the GPR17 receptor dual profile 393
GPR17 receptor modulators and their therapeutic implications: review of recent patents 389
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 384
The G Protein-Coupled Receptor GPR17: Overview and Update 370
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 363
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 355
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 325
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 297
“Synthesis and α-Adrenoreceptor Blocking Properties of Phenoxybenzamine-Related (2-Chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) Amines”. 289
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 286
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 282
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 274
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 274
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 270
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 265
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 264
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 264
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 262
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 262
5HT2B receptor antagonists: a probe for spotting the pharmacophore 258
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 249
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 244
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 244
“New Pyridazinones: Synthesis and Correlation Between Structure and α-Blocking Activity”. 242
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 240
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 237
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 236
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 236
"[4-[[N-(3-Chlorophenyl)carbamoyl]-2-butynyl]-trimethylammonium (McN-A-343)-Related Compounds. Effect of the Butynyl Chain Inclusion into an Aromatic Unit of the Potency for Muscarinic Receptors 236
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 234
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 234
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 232
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 231
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 230
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 225
New sensible method to quantize the intestinal absorption of receptor ligands 224
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 224
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 223
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 221
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 220
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 220
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 218
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 218
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 218
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 217
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 217
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 215
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 214
Antiviral properties of deazaadenine nucleoside derivatives 214
Analogues of Prazosin That Bear a Benextramine-Related Polyamine Backbone Exhibit Different Antagonism toward alpha1-Adrenoceptor Subtypes 213
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 213
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 212
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 212
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 212
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 210
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 210
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 209
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 209
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 208
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 208
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 207
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 206
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 206
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 204
Adenosine receptor modeling: what does the A2A crystal structure tell us? 204
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 203
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 203
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 202
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 201
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 198
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 198
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 198
Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines 197
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 197
Synthesis and α1-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone 197
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 195
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 193
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 192
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 191
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 190
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 189
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 188
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 188
“Synthesis and Pharmacological Activity of Some New Pyridazinones”. 187
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 187
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 185
“Synthesis and α1-Antagonist Activity of New Prazosin-and Benextramine-Related Tetraamine Disulfides”. 185
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 185
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 183
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 183
3-arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands 182
Highly chiral muscarinic ligands: The discovery of (2S,2 ' R,3 ' S,5 ' R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M-2 partial agonist 182
Totale 25.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 0 0 0 0 0 0 356
2021/20221.977 189 478 39 103 99 65 100 154 145 228 147 230
2022/20232.322 257 120 84 384 260 312 13 146 385 121 170 70
2023/20241.769 252 102 112 59 71 115 86 103 198 70 63 538
2024/20255.716 203 146 485 264 159 340 639 1.449 429 403 399 800
2025/20269.157 534 593 1.706 1.137 959 660 1.363 583 546 520 447 109
Totale 35.695